Results From the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Time: 12:30 pm
day: Day One

Details:

• Translational research leading up to the development of clinically relevant urinary biomarkers for ADPKD
• Preclinical data supporting the use of the newly-developed biomarkers in RGLS4326 clinical trials
• Clinical data demonstrating target engagement and proof of mechanism in early phase of clinical development

Speakers: